Is AD a Stress-Related Disorder? Focus on the HPA Axis and Its Promising Therapeutic Targets

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that has important health and economic impacts in the elderly. Despite a better understanding of the molecular mechanisms leading to the appearance of major pathological hallmarks (senile plaques and neurofibrillary tangles), effective treatments are still lacking. Sporadic AD forms (98% of all cases) are multifactorial, and a panoply of risk factors have been identified. While the major risk factor is aging, growing evidence suggests that chronic stress or stress-related disorders increase the probability to develop AD. An early dysregulation of the hypothalamic-pituitary-adrenal axis (HPA axis or stress axis) has been observed in patients. The direct consequence of such perturbation is an oversecretion of glucocorticoids (GC) associated with an impairment of its receptors (glucocorticoid receptors, GR). These steroids hormones easily penetrate the brain and act in synergy with excitatory amino acids. An overexposure could be highly toxic in limbic structures (prefrontal cortex and hippocampus) and contribute in the cognitive decline occurring in AD. GC and GR dysregulations seem to be involved in lots of functions disturbed in AD and a vicious cycle appears, where AD induces HPA axis dysregulation, which in turn potentiates the pathology. This review article presents some preclinical and clinical studies focusing on the HPA axis hormones and their receptors to fight AD. Due to its primordial role in the maintenance of homeostasis, the HPA axis appears as a key-actor in the etiology of AD and a prime target to tackle AD by offering multiple angles of action.

The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey

“…Intriguingly, in animal models of acute physical and social restraints, an impairment of serotonin metabolism in the central nervous system was reported, with an alteration of immune response ( Medina-Martel et al, 2013 ). In humans, stress drives several diseases, including cognitive disorders such as AD ( Canet et al, 2019 ). Acute stress induces a neuroinflammatory response characterized by the release of several pro-inflammatory molecules and microglial activation that is a common feature of several neurodegenerative diseases ( Sharma and Kanneganti, 2016 ).…”

The Immunopathogenesis of Alzheimer’s Disease Is Related to the Composition of Gut Microbiota

“…Furthermore, persistent over-activation of the HPA axis by chronic stress appears to be involved crucially in cognitive decline [ 228 ], possibly also by modulating the microbiota: chronic stress was shown to decrease the number of Lactobacilli [ 229 ].…”

The Role of Chronic Stress as a Trigger for the Alzheimer Disease Continuum

“…This signaling is disrupted in human aging resulting in an altered circadian rhythm as indicated above and, as a snake that bites its own tail, sleep disturbances may cause an increase in cortisol secretion (Schouten et al, 2019). Moreover, cognitive and affective neural networks can be altered during aging due to the possible link between both systems and adrenal medulla, the last component of HPA axis (Canet et al, 2019;Konishi et al, 2019). Chronic stress via dysregulation of the HPA-axis can be a trigger of co-morbid depression in neurodegenerative diseases (Rapp et al, 2011;Du and Pang, 2015).…”